Translate this page into:
Primary Fibroblastic Osteosarcoma of the Lumbar Vertebra on Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Address for correspondence: Dr. Jae Pil Hwang, Department of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, South Korea. E-mail: zandazanda@nate.com
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Abstract
A 37-year-old man who presented with one year history of lower back and right buttock pain was investigated with contrast enhanced computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography which revealed a diagnosis of primary fibroblastic osteosarcoma of the lumbar vertebra. This case highlights the importance of PET/CT imaging.
Keywords
Fibroblastic
fluorine-18-fluorodeoxyglucose
osteosarcoma
positron emission tomography/computed tomography
A 37-year-old man presented with one year history of lower back and right buttock pain. He was investigated with contrast-enhanced computed tomography (CT), magnetic resonance imaging (MRI), and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Enhanced CT and MRI images show an T1 iso-to-slight high-signal intensity mass with irregular osteolytic lesion in the vertebral body, both pedicle, transverse, and spinous process of L4 with bony cortical expansion and destruction. Moreover, 18F-FDG PET/CT demonstrated an area of increased 18F-FDG uptake with a maximum standardized value (SUVmax) of 3.2, corresponding to an osteolytic lesion occupying the right vertebral body, both pedicle, transverse, and spinous process of L4 spine suspicious for malignant bone tumor [Figure 1]. No other areas of abnormal 18F-FDG uptake were detected in the rest of the body. Based on this PET/CT finding, the patient had a biopsy of the L4 lesion. Histology demonstrated the presence of a fibroblastic osteosarcoma (OS), and the patient was addressed to surgical resection.

OS is a highly malignant sarcoma with the production of osteoid matrix. The most common sites of origin are the metaphyseal regions of the distal femur, proximal tibia, and proximal humerus.[1]
Vertebral involvement is very rare with 2%–4% of all cases and fibroblastic subtype is a low rate with 25% of all conventional OS.[2] It tends to occur in a slightly older age group, with a mean age of 38 years, than OS of the extremity.[3]
The role of 18F-FDG PET/CT in patients with appendicular OS is well known for initial staging, detecting recurrence, and/or response monitoring, whereas only a little articles evaluated the usefulness of primary vertebral OS.[45]
The present case 18F-FDG PET/CT was useful in evaluating a malignant potential of the spine mimicking bone metastasis or benign bone tumor in a patient with back pain. Although rare, primary fibroblastic OS should be considered one of the differential diagnoses of vertebral lesions detected by 18F-FDG PET/CT.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Osteosarcoma of the lumbar vertebra: Case report and a review of the literature: Rare localization with long survival. Arch Orthop Trauma Surg. 2009;129:1701-5.
- [Google Scholar]
- Bone and Joint Imaging (3rd ed). Philadelphia: Saunders; 2005.
- Pictorial review: Imaging of primary osteosarcoma of the spine. Clin Radiol. 1996;51:325-9.
- [Google Scholar]
- Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18F-FDG PET/CT and MRI. Eur J Nucl Med Mol Imaging. 2014;41:1553-62.
- [Google Scholar]
- The role of fluorine-18-fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma. Radiol Oncol. 2013;47:97-102.
- [Google Scholar]
